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Protein 4.2 is a major protein of the human erythrocyte membrane. It has previously been 
shown to be N-myristoylated. After labeling of intact human erythrocytes with [3H]palmitic acid, 
radioactivity was found to be associated with protein 4.2 by immunoprecipitation of peripheral 
membrane proteins extracted at pH 11 from ghosts with antL(4.2) sera, followed by SDSPAGE and 
fluorography. The fatty acid linked to protein 4.2 was identified as palmitic acid after hydrolysis of 
protein and thin-layer chromatography of the fatty acid extracted in the organic phase. Protein 4.2 
could be depalmitoylated with hydroxylamine, suggesting a thioester linkage. Depalmitoylated pro- 
tein 4.2 showed significantly decreased binding to protein-4.2-depleted membranes, compared to 
native protein 4.2. 
The shape and mechanical stability of the erythrocyte 
membrane is maintained by proteins constituting a filamen- 
tous scaffold, the membrane cytoskeleton, underlying the 
lipid bilayer [l, 21. This cytoskeleton is composed mainly of 
spectrin tetramers held together at their junctions by short 
actin filaments. The interaction between spectrin and actin is 
strengthened by protein 4.1, which also serves as a link be- 
tween the cytoskeleton and the lipid bilayer through interac- 
tions with spectrin and with glycophorin [3, 41. The linkage 
of spectrin to the bilayer is also mediated by interactions of 
ankyrin with p spectrin and the cytoplasmic domain of band 
3 [ S ] .  In human erythrocytes, band 3 further associates with 
another 72000 M, peripheral membrane protein, namely band 
4.2. Human erythrocyte protein 4.2 is a major protein in the 
membrane skeletal network that represents about 5 %  of the 
total protein mass of the erythrocyte membrane (reviewed in 
[6]). Protein 4.2 associates with the cytoplasmic domain of 
the anion exchanger, band 3 [7]. It also interacts with ankyrin 
in solution and possibly also with protein 4.1 [7, 81. Protein 
4.2 deficiency has been related to various types of hemolytic 
anemias [6]. Immunoreactive forms of protein 4.2 also occur 
in association with the plasma membrane of non-erythroid 
cells [9]. Cloning of protein 4.2 cDNA has revealed that it is 
a member of the transglutaminase family of enzymes [lo]. 
In chicken, rabbit, rat and human erythrocytes, several 
membrane proteins, including ankyrin [ l l ] ,  band 3 [12], a 
55000 M, cytoskeletal protein [13-151, protein 4.1 [16] and 
a subpopulation of spectrin [17], have been reported to be 
palmitoylated. Fatty-acid acylation of proteins confers an ex- 
tra hydrophobic moiety to proteins, which promotes hy- 
drophobic protein-membrane and protein-protein interactions 
[18, 191. Protein 4.2 has recently been reported to be N- 
myristoylated 1201. We report here that protein 4.2 is also 
palmitoylated. We also demonstrate that depalmitoylation of 
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native protein 4.2 significantly decreases its binding to 4.2- 
depleted membrane vesicles. 
MATERIALS AND METHODS 
Materials 
Bolton-Hunter reagent, [3H]palmitic acid and [3H]myris- 
tic acid were purchased from Du Pont/NEN. Leupeptin, 
aprotinin, dithiothreitol, dithioerythritol, phenylmethylsulfo- 
nyl fluoride(PhMeSO,F), Dulbecco’s modified Eagle’s medi- 
um(DMEM), protein-A-bearing Staphylococcus aureus cells, 
EGTA and fatty-acid-free BSA were from Sigma Chemical 
Co. Q-Sepharose was obtained from Pharmacia, horse-rad- 
ish-conjugated anti-rabbit IgG, Tween 20 and gelatin were 
from Biorad. All other reagents were of analytical grade. 
Preparation and radiolabeling of cells 
Blood was collected from normal, healthy human volun- 
teers in DMEM. Cells were collected by centrifugation and 
washed with DMEM to remove the buffy coat. Packed eryth- 
rocytes (120 pl) were incubated at 37°C with DMEM (8 ml) 
containing 20 pCi [3H]palmitic acid and 160.8 pg BSA 
(fatty-acid-free). After 3 h, cells were pelleted, washed five 
times with DMEM containing 5 mg/ml BSA, twice with 
155 mM NaCl, 7.5 mM sodium phosphate, 0.1 mM 
Na,EDTA, pH 7.5 and lysed with lysis buffer (7.5 mM so- 
dium phosphate, pH 7.5) containing l mM PhMeSO,F, 
0.1 mM leupeptin and 30 pg/ml aprotinin. Ghosts were pre- 
cipitated by centrifugation at 18 000 rpm (Sorvall SS 34 ro- 
tor) for 20 min, followed by two washes in lysis buffer. 
Purification of protein 4.2 
Human erythrocyte protein 4.2 was purified as described 
by Friedrichs et al. [9] with some modifications. Erythrocyte 
ghosts were incubated for 30 min at 37°C with 30 volumes 
0.1 mM EGTA, pH 8.5. Membranes were pelleted at 19 
000 rpm (Sorvall SS 34 rotor) for 25 min and the precipitated 
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membranes were washed once with 0.1 mM EGTA, pH 8.5. 
The membranes were then incubated for 30 min at 37 "C with 
5 volumes 1 M KC1, 1 mM dithiothreitol. Membranes were 
again pelleted at 19000 rpm (Sorvall SS 34 rotor) for 25 min. 
The precipitated membranes were collected and incubated 
in 5 volumes 0.1 mM EDTA, pH 11, for 45 min at 37°C. 
Membranes were pelleted by centrifugation at 100000 g for 
60 min. The supernatant, containing protein 4.2, was used for 
further purification. This supernatant will be referred to as 
the pH 11 extract. The supernatant was dialyzed against 
5 mM sodium phosphate, 0.1 mM EDTA, 0.2 mM dithio- 
erythritol, pH7.4 (buffer A) and loaded on a Q-Sepharose 
column equilibrated against the same buffer. The column was 
washed with 50 mM NaCl in equilibration buffer and eluted 
with a linear gradient of 50-400 mM NaCl in equilibration 
buffer. Fractions containing purified protein 4.2, as checked 
by SDSPAGE, were pooled and concentrated using an Ami- 
con Centricon-10 concentrator. 
Raising of antibodies 
In order to remove any minor contaminants, purified pro- 
tein 4.2 was electrophoresed on 10% SDS/polyacrylamide 
gels; the band corresponding to protein 4.2 was excised from 
the gels and electroeluted. Antibodies against this purified 
protein were raised in adult male rabbits. 
Immunoprecipitation of protein 4.2 
from [3H]palmitic-acid-labeled erythrocytes 
Extracts (at pH 11) were prepared from [3H]palmitic- 
acid-labeled erythrocyte ghosts as described above. The ex- 
tract was concentrated and used for immunoprecipitation 
with anti-(4.2) sera as described by Firestone and Winguth 
[21]. 10% formalin-fixed protein-A-bearing S. aureus cells 
were washed in TETN250 immunoadsorption buffer (25 mM 
Tris/HCl, pH 7.5, containing 5 mM EDTA, 250 mM NaCl 
and 1% Trition X-100). The pH 11 extract was incubated 
with anti-(4.2) sera for 1 h, followed by incubation for 1 h 
with washed protein A-bearing S. aureus at 28°C with stir- 
ring. The samples were sedimented at 2500 rpm followed by 
three washes with 1-ml aliquots of ice-cold 5 mM sodium 
phosphate, pH 7.6, containing 0.5 mM EGTA, 0.5 mM 
dithiothreitol, 1 mM EDTA, 0.1% Triton X-100 and 1 mg/ml 
gelatin. The pellet was boiled for 10min in SDS sample 
buffer, run on SDS/polyacrylamide gels and analyzed by flu- 
orography as described by Bonner and Laskey [22]. Western 
blotting was performed as described by Towbin et al. [23]. 
Incubation with hydroxyamine 
Incubations with hydroxyamine were carried out using 
various concentrations of hydroxyamine at 22°C for 30 min 
with the protein extract obtained at pH 11. In separate experi- 
ments, SDS/polyacrylamide gels of the [3H]palmitic-acid-la- 
beled extracts were treated with neutral hydroxyamine (1 M) 
or chloroforndmethanol for 6 h prior to fluorography of the 
gels. 
Analysis of the protein-bound 3H-labeled fatty acid 
Intact human erythrocytes (500 pl) were labeled with 
125 pCi [3H]palmitic acid as described above. The concen- 
trated pH 11 extract was solubilized in SDS sample buffer 
and electrophoresed on 10% SDS/polyacrylamide gels. Pro- 
tein 4.2 was excised from the gel. The gel slices were incu- 
bated with 1 ml 1.5 M NaOH at 30°C for 3 h [24]. The 
pH was then adjusted to 1-2 with 6 M HC1. The hydrolyzate 
was extracted with chlorofordmethanol and the organic 
phase was dried under nitrogen. The extracted lipid was ana- 
lyzed by ascending chromatography on a reverse-phase C,, 
TLC plate using acetonitrile/acetic acid (1 : 1, by vol.) as the 
mobile phase. [3H]palmitic acid and [3H]myristic acid were 
used as standards. The plate was scraped and the radio- 
activity determined in parts to determine the relative nugra- 
tion of radiolabeled species in the samples. 
Determination of the stoichiometry of the palmitoylation 
of native protein 4.2 by gas-liquid chromatography 
Unlabeled, purified protein 4.2 was electrophoresed on 
SDS/polyacrylamide gels and the band corresponding to pro- 
tein 4.2 was electroeluted. Protein was estimated using the 
bicinchoninic-acid-assay reagent (Pierce). Protein-bound 
fatty acid was extracted as described above. Fatty acid meth- 
yl esters were prepared using ethereal diazomethane and ana- 
lyzed by gas-liquid chromatography on a Hewlett-Packard 
5890 Gas Chromatograph fitted with an integrator using a 
10% diethylene glycol/succinate column (1.8 mX2 mm in- 
ternal diameter) and a flame-ionization detector. Methyl pen- 
tadecanoate was used as an internal standard. 
Radioiodination of protein 4.2 
Protein 4.2 (native or depalmitoylated) was radiolabeled 
with Iz5I-labeled Bolton-Hunter reagent. The Bolton-Hunter 
reagent was dried under a stream of nitrogen and 1 M borate, 
pH 8.5, was added to it. The protein to be iodinated was 
made 100 mM in sodium borate, pH 8.5. 125 pCi Bolton- 
Hunter reagent was added to 500 pg protein and the reaction 
was allowed to proceed on ice for 90 min. The protein was 
then dialyzed against 5 mM sodium phosphate, 0.5 mM 
EGTA, 0.5 mM dithiothreitol, 120 mM KCl, pH 8. 
Preparation of protein 4.2-depleted vesicles 
This was carried out as described above. The membranes 
remaining after extraction of band 4.2 at pH 11 were used as 
band-4.2-depleted vesicles. 
For some experiments, vesicles were digested with 1 pg/ 
ml chymotrypsin at a vesicle concentration of 2 mgiml in 
5 mM sodium phosphate, 0.5 mM EGTA, pH 8, at O'C for 
30 min. The reaction was terminated by adding 100 pg/ml 
PhMeSO,F, and the vesicles were washed once in 5 mM so- 
dium phosphate, 0.5 mM EGTA, pH 8. 
Membrane-binding assay 
This was performed as described by Korsgren and Cohen 
[7]. Radioiodinated protein 4.2 (0- 150 pg/ml) was added to 
50 pg/ml protein-4.2-depleted membrane vesicles, in a total 
volume of 300 pl, in a medium containing 120 mM KCl, 
5 mM sodium phosphate, 0.5 mM EGTA, 0.5 mM dithio- 
threitol, 1 mg/ml BSA and 0.02% sodium azide. The reaction 
mixtures were incubated overnight (12 h) at 25°C. Two 100- 
pl samples were removed from each tube and centnfuged 
at 100000 g for 25 min. The supernatant was remoked by 
aspiration, the protein-4.2-bound membranes were washed, 
pelleted again and radioactivity determined in a y counter. At 
each concentration of '251-labeled protein 4.2, control tubes 
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Fig. 1. lmmunoprecipitation of the [3H]palmitic acid-labeled 
erythrocyte peripheral membrane proteins extracted at pH 11 
with antb(4.2) sera. Lane A, Western blot of purified protein 4.2 
with antG(4.2) sera. Lane B, immunoprecipitation of [3H]palmitic 
acid-labeled erythrocyte peripheral membrane proteins with anti- 
(4.2) sera, followed by SDSPAGE and fluorography. Lane c, West- 
em blot of erythrocyte ghosts with anti-(4.2) sera. 
lacking membranes were incubated, centrifuged as above and 
the radioactivity determined in order to account for protein 
4.2 adhering to the walls of the tubes. For some experiments, 
chymotrypsin-treated vesicles were used and the membrane- 
binding assay was carried out as described above. 
Competition by unlabeled band 4.2 for binding 
of 1251-labeled band 4.2 to membranes stripped at pH 11 
'2sI-labeled band 4.2 (36 pg/ml) was incubated with 
50 pg/ml proteins stripped from membranes by exposure to 
pH 11 and the indicated concentrations of unlabeled band 
4.2. Membrane-binding assays were performed as described 
above. 
RESULTS 
Identification of the ["H]72000-Mr protein 
obtained after labeling of human erythrocytes 
with ["Hlpalmitic acid 
In order to identify the 72000-Mr protein that is labeled 
on incubation of human erythrocytes with [3H]palmitic acid, 
CIHIpalmitic-acid-labeled erythrocyte ghosts were subjected 
to extraction of peripheral membrane proteins as described 
above. After concentration, the pH 11 extract was subjected 
to immunochemical analysis using antL(4.2) sera. Fig. 1 
shows that the antisera was specific for protein 4.2. The anti- 
gen-antibody complex obtained after incubation of the la- 
beled pH 11 extract with antb(4.2) sera, was precipitated 
using protein-A-bearing S. aureus cells. The pelleted proteins 
were analyzed by SDSPAGE, followed by fluorography. A 
72 000-M, band was obtained after fluorography, confirming 
that the polypeptide labeled in that region is indeed protein 
4.2. 
Identification of the fatty acid associated with protein 4.2 
In order to recover the protein-4.2-linked fatty acid from 
the protein, the radiolabeled pH 11 extract was electropho- 
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Fig. 2. Identification of fatty acids after hydrolysis of human 
erythrocyte protein 4.2 recovered from [jHIpalmitic acid-labeled 
erythrocytes. The organic extract of hydrolysed protein 4.2 was 
dried and run on reverse-phase C,, TLC plates with ['Hlmyristic 
acid ['Hlpalmitic acid as standards. After ascending chromatogra- 
phy, samples 1 cm in height and 2 cm in width were scraped from 
the plate and radioactivity determined. 
resed on SDS/polyacrylamide gels and protein 4.2 was ex- 
cised from the gels. The gel slices were subjected to alkaline 
hydrolysis, extraction of the fatty acid in the organic phase 
and reverse phase TLC. The labeled species comigrated with 
[3H]palmitic acid, demonstrating that the fatty acid incorpo- 
rated into band 4.2 is palmitic acid (Fig. 2). Association of 
palmitic acid with native, unlabeled protein 4.2 was further 
confirmed by gas-liquid chromatography of the fatty acid lib- 
erated from unlabeled protein 4.2. The molar ratio of protein 
4.2/palmitic acid was found to be 1 : 2. However, this esti- 
mate should be treated with caution due to background con- 
tamination probably arising from the detergent associated 
with the electroeluted protein 4.2 from which the fatty acid 
was extracted. 
Sensitivity of the protein-4.2-linked fatty acid to cleavage 
by hydroxyamine 
In order to depalmitoylate protein 4.2, the pH 11 extract 
was treated with different concentrations of hydroxyamine 
for 30 min at 22°C. This treatment did not lead to any alter- 
ations in proteins as evidenced by Coomassie blue staining 
of the treated and untreated pH 11 extracts. However, hydro- 
xyamine at a concentration of 1 M caused depalmitoylation 
of protein 4.2 as assessed by SDSRAGE and fluorography 
of treated and untreated [3H]palmitic-acid-labeled pH 11 ex- 
tracts (Fig. 3). Gels of ["Hlpalmitic-acid-labeled peripheral 
protein extracts obtained at pH 11 were also treated with 
chloroform/methanol or neutral hydroxyamine and subjected 
to fluorography. The band-4.2-associated label was insensi- 
tive to chlorofomdmethanol, but sensitive to neutral hydro- 
xyamine (data not shown). This suggested that the fatty acid 
was linked by a thioester bond to band 4.2. 
Binding of ['Z51]band 4.2 to band-4.2-depleted membranes 
Binding was studied using both native and depalmitoy- 
lated protein 4.2. In the case of depalmitoylated band 4.2, the 
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Fig. 3. Treatment of [3HH]palmitic acid-labeled erythrocyte mem- 
brane proteins extracted at pH 11 with hydroxyamine at 22°C 
for 30 min. Peripheral membrane proteins obtained after labeling of 
cells with [3H]palmitic acid were treated with hydroxyamine at 22 "C 
for 30 min, followed by SDSRACE and fluorography. Lane (A) con- 
trol; lane (B) 0.25 M hydroxyamine; lane (C) 0.5 M hydroxyamine; 
lane (D) 1 M hydroxyamine. 
pH 11 peripheral protein extract was immediately dialyzed 
against buffer A at 4°C after treatment with 1 M hydroxy- 
amine as described above. The dialyzate was used for purifi- 
cation of depalmitoylated protein 4.2 by chromatography on 
Q- Sepharose as described above. Both native and depalmi- 
toylated band 4.2 were labeled with Bolton-Hunter reagent 
as described in Materials and Methods. Both native and de- 
palmitoylated protein 4.2 bound to the membranes in a satu- 
rable manner (Fig. 4 A). The possibility of studying non- 
specific binding in these cases was ruled out by the fact that 
the binding of ['251]band 4.2 to chymotrypsin-treated vesicles 
(representing non-specific binding) was only about 15 % of 
the binding of native band 4.2 to the membranes (Fig. 4A). 
Moreover, increasing concentrations of unlabeled band 4.2 
competed with [Iz5I]band 4.2 for binding to pH-11-stripped 
membranes (Fig. 5) .  
The binding of depalmitoylated band 4.2 was signifi- 
cantly lower than that of native band 4.2. Scatchard analysis 
of the binding data shown in Fig. 4A gave a concave plot for 
native band 4.2 (Fig. 4 B), as described in [7], demonstrating 
high-affinity and low-affinity binding of band 4.2 to the 
membranes. In the case of depalmitoylated protein 4.2, the 
high-affinity-binding component was not observed. Extrapo- 
lation of the curve on the x axis, gave a binding capacity of 
280 mg band 4.2lg vesicle protein in our experiments with 
native band 4.2. However, this was reduced to 108 mg band 
4.2lg vesicle protein in the case of depalmitoylated band 4.2. 
DISCUSSION 
Protein 4.2 is one of the major proteins of the human 
erythrocyte membrane, representing 5 %  of the protein. Pro- 
tein 4.2 is essential for the normal functioning of the erythro- 
cyte membrane, since defects and deficiencies in band 4.2 
result in fragile and abnormally shaped erythrocytes, leading 
to hemolytic anemia [25-271. Protein 4.2 associates with the 
cytoplasmic domain of band 3 [7] and also with ankyrin [8]. 
Band 3 appears to represent the major high-affinity binding 
site for protein 4.2 on the erythrocyte membrane [7]. 
Although protein 4.2 is a peripheral membrane protein, it 
is resistant to extraction from the membrane, unless harsh 
conditions such as high pH or mildly chaotropic agents are 
used [28]. Myristoylation of protein 4.2 probably contributes 
towards this strong interaction with the membrane [20]. We 
now demonstrate that, in addition to being myristoylated, 
band 4.2 is also palmitoylated. 
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Fig. 4. Analysis of the binding of band 4.2 to band 4.2-depleted 
vesicles. (A) Binding of '251-labeled band 4.2 to pH 11-stripped (i.e. 
band 4.2-depleted) vesicles. The binding was as described in Materi- 
als and Methods. (0) Control band 4.2; (0) depalmitoylated band 
4.2; (W) binding to pH-11-stripped vesicles digested with 1 pglml 
chymotrypsin. (B) Scatchard plots of the binding data shown In (A). 
Data were analyzed using the software ENZFITTER (Elsevier Bio- 
soft). 
Palmitoylation is found in diverse membrane proteins in- 
cluding viral glycoproteins [29, 301, the p2 adrenergic recep- 
tor [31], the acetylcholine receptor [32], rhodopsin [33, 341, 
ras proteins [35], the transferrin receptor [36] and the protein 
tyrosine kinase p56Ick [37]. Palmitoylation not only serves to 
anchor proteins to membranes [38], but also plays such im- 
portant roles as regulation of protein-protein interactions 
[31], regulation of receptor-mediated endocytosis of the 
transferrin receptor [39] and phosphorylation of transgluta- 
minase [40]. Erythrocyte membrane proteins which are 
known to be palmitoylated include p55, a peripheral mem- 
brane protein of human erythrocytes [13-151, band 3 [12], 
chicken and rabbit erythrocyte ankyrin [l l] ,  rat erythrocyte 
band 4.1 [16] and the Rh antigen [41, 421. 
In the present investigation, immunoprecipitation of the 
[3H]palmitic acid-labeled 72000-M, protein of the human 
erythrocyte membrane with anti-(4.2) sera has confirmed that 
protein 4.2 is acylated. Analysis of the 4.2-linked fatty acid 
has shown that it is palmitoylated. Since mature human 
erythrocytes lack a protein synthesising machinery, the meta- 
bolic labeling of protein 4.2 with [3H]palmitic acid must be, 
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Fig.5. Competition by unlabeled band 4.2 for binding of 
pZ51]band 4.2 to membranes. Binding was measured as described 
in Materials and Methods. 
as expected, a post-translational modification. The sensitivity 
of the protein - palmitic-acid linkage to cleavage by hydroxy- 
amine suggests that the palmitic acid is present in the usual 
thioester linkage. 
Depalmitoylation with hydroxyamine has been used to 
study the functional properties of rhodopsin [43] and the in- 
fluenza virus spike glycoprotein [44]. The questions of con- 
formational changes which are associated with the technique 
of site-directed mutagenesis do not arise in such experiments. 
We have utilized a similar approach to depalmitoylate protein 
4.2. The association of depalmitoylated protein 4.2 with pro- 
tein-4.2-depleted membranes is significantly decreased com- 
pared to native protein 4.2. It has previously been reported 
that there is a high-affinity and a low-affinity binding compo- 
nent for protein 4.2 binding to membranes [7]. Scatchard 
analysis of the binding data for control and depalmitoylated 
protein 4.2 suggests that the high-affinity binding component 
is affected by palmitoylation. Whereas control protein 4.2 
showed a binding capacity of 280mglg vesicle protein in 
our experiments, depalmitoylated protein 4.2 gave a value of 
108 mglg vesicle protein. Korsgren and Cohen suggested that 
the high-affinity binding component represents band 3 on the 
membrane, since this component is affected when band 3 on 
the membrane is digested with chymotrypsin. Our findings 
raise the possibility that the concave Scatchard plot may also 
be due to the heterogeneity in native protein 4.2 with respect 
to its extent of palmitoylation. Covalent attachment of pal- 
mitic acid to proteins may modulate protein-protein interac- 
tions. Assuming that the high-affinity binding site is band 3, 
it is possible that palmitoylation of protein 4.2 favours its 
interaction with band 3 on the membrane. Binding studies 
with band 3 in solution will be needed to resolve this issue. 
Band 4.2 has extensive similarity with the Ca2+-depen- 
dent cross-linking proteins, the transglutaminases [45], and 
the two protein classes probably arose from a common an- 
cestral gene [ lo]. Interestingly, keratinocyte transglutaminase 
has also been reported to be both myristoylated and palmi- 
toylated [46]. It has further been demonstrated that transglu- 
taminase mutants in which the cysteine cluster responsible 
for palmitic acid thioesterification, is deleted, are cytosolic 
[40]. The protein tyrosine kinase ~ 5 6 ' ' ~  of T cells is also both 
myristoylated and palmitoylated [37]. 
In conclusion, the present data suggest that palmitoyla- 
tion of protein 4.2 modulates its binding to the erythrocyte 
membrane. A tightly membrane- associated palmitoylated 
form of spectrin probably represents a phosphoform of 
spectrin [ 171. Further investigations into the relationship be- 
tween palmitoylation and phosphorylation of protein 4.2 may 
provide insight into the regulatory significance of these post- 
translational modifications. 
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